- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/42 - Cancer antigens
Patent holdings for IPC class A61K 40/42
Total number of patents in this class: 1705
10-year publication summary
|
0
|
1
|
9
|
33
|
106
|
145
|
64
|
55
|
811
|
115
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4382 |
46 |
| The Regents of the University of California | 20355 |
44 |
| Memorial Sloan-Kettering Cancer Center | 1985 |
31 |
| Kite Pharma, Inc. | 425 |
27 |
| Board of Regents, The University of Texas System | 5989 |
25 |
| Immunitybio, Inc. | 485 |
25 |
| Juno Therapeutics, Inc. | 465 |
22 |
| City of Hope | 1008 |
20 |
| Iovance Biotherapeutics, Inc. | 356 |
20 |
| Dana-Farber Cancer Institute, Inc. | 2640 |
19 |
| Autolus Limited | 264 |
18 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 997 |
18 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2942 |
18 |
| Novartis AG | 10494 |
17 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
17 |
| The General Hospital Corporation | 4793 |
17 |
| Immatics Biotechnologies GmbH | 1137 |
16 |
| Fred Hutchinson Cancer Center | 458 |
15 |
| FATE Therapeutics, Inc. | 219 |
14 |
| Janssen Biotech, Inc. | 1612 |
14 |
| Other owners | 1262 |